Tag: nasdaq:agio

April 7, 2021

5 Top Biotechnology ETFs

For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.
January 26, 2021

Top Life Science ETFs of 2020

What are the top life science ETFs? Here's a look at the five best-performing life science ETFs of 2020.
November 13, 2019

Agios Pharmaceuticals Closes Public Offering

The company has additionally announced the option for its underwriters to purchase an additional 1.23 million shares at US$31 each.
January 1, 2019

An Investor’s Guide to Clinical Trials

Clinical trials can be one of the more challenging US Food and Drug Administration processes to understand, but grasping the...
December 3, 2018

Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial

Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today presented...
November 16, 2018

Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma

Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today presented...
October 2, 2018

3 Top Biotech Stocks on the TSX Year-to-Date

Which biotech stocks on the TSX have performed the best year-to-date? These three companies have risen to the top of...